One
interesting new FDA approval has come up as Afrezza, rapid acting Human insulin
in the form of inhalation powder, by Mankind. Inhale and control the blood
glucose, looks simple now. Well, for those who have not heard or read about
‘Afrezza’; it is a rapid acting inhaled insulin powder.
When
the insulin is inhaled through the device, the powder is aerosolized and
delivered to the lung. Afrezza is specifically indicated to improve glycemic
control in adult patients with diabetes mellitus. Afrezza is supplied as a
powder to be administered via oral inhalation.
Limitations of Use: Afrezza is not a
substitute for long-acting insulin. Afrezza must be used in combination with
long-acting insulin in patients with type 1 diabetes mellitus. Afrezza is not
recommended for the treatment of diabetic ketoacidosis.
More
information about the drug can be found at www.afrezza.com
Well,
having a new product in the market and getting is positioned in the favor of
consumer’s need could be a gruesome process for any company. , Turacoz’s Brand communication
team can plan and assist new product launch and develop strong brand
communication for your product/services to reach the target audience
effectively and efficiently.
We
strongly focus on identification of target audience/consumers, communication
mediums, and the big idea of the campaign, hitches and budget of the project.
Our ground-breaking techniques to represent drug information to the target
audience will enhance the product launch and ultimately sales within desired
time line. We believe in 360 degree brand communication which involves print,
media and digital solutions for your product branding. We create clear,
innovative and interactive communication messages.
The
documents that can help in the branding or positioning Alfrezza could be any
or many of the following:
No comments:
Post a Comment